Methods for measurement of LDL-cholesterol: A critical assessment of direct measurement by homogeneous assays versus calculation

Clinical Chemistry

Volumn 48, Issue 2, 2002, Pages 236-254

  Nauck, Matthias ^a   Warnick, G Russell ^a   Rifai, Nader ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANALYTIC METHOD; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HORMONE SUBSTITUTION; HYPERCHOLESTEROLEMIA; KIDNEY FAILURE; LIVER FAILURE; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 0036155927     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.2.236     Document Type: Review

References (115)

1. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
2. Incidence of coronary heart disease and lipoprotein levels: The Framingham study
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
5. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
6. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
7. Helsinki heart study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
8. Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents
9. National Cholesterol Education Program recommendations for measurements of low-density lipoprotein cholesterol: Executive summary
10. Heterogeneity of human plasma lipoprotein(a). Isolation and characterization of the lipoprotein subspecies and their apoproteins
11. Low-density lipoprotein subclass patterns and risk of myocardial infarction
12. Low density lipoprotein particle size and coronary artery disease
13. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma
14. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: Results from the Framingham heart study
15. Standardization of lipid and lipoprotein measurement
16. Interlaboratory testing of the transferability of a candidate reference method for total cholesterol in serum
17. A reference method laboratory network for cholesterol: A model for standardization and improvement of clinical laboratory measurements
18. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human plasma
19. Optimization of β-quantification methods for high-throughput applications
20. A system for phenotyping hyperlipoproteinemia
21. Enzymic determination of cholesterol in serum lipoproteins separated by electrophoresis
22. Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel
23. Improved techniques for assessment of plasma lipoprotein patterns. I. Precipitation in gels after electrophoreses with polyanionic compounds
24. Improved assessment of plasma lipoprotein patterns. III. Direct measurement of lipoproteins after gel-electrophoresis
25. Fortschritte in der analytik des lipoprotein-musters
26. Comparison of two methods for very low density and low density lipoprotein cholesterol determination
27. Quantification of plasma lipoprotein cholesterol: A simple procedure for enzymatic determination of cholesterol in electrophoretically separated lipoproteins
28. Lipoprotein quantification: An electrophoretic method compared with the Lipid Research Clinics method
29. Measurement of lipoprotein cholesterol with the cholesterol dehydrogenase method after electrophoretic lipoprotein separation. A comparison with quantitative lipoprotein electrophoresis and the ultracentrifugation method
30. Determination of HDL and LDL-cholesterol by cholesterol dehydrogenase
31. A specific method for the direct determination of lipoprotein cholesterol in electrophoretic patterns
32. Improved method for enzymic determination of cholesterol in lipoproteins separated by electrophoresis on thin layer agarose gels
33. A screening method for abnormally high lipoprotein(a) concentrations by agarose lipoprotein electrophoresis
34. Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining
35. Quantitative determination of cholesterol in lipoprotein fractions by electrophoresis
36. Comparison of a new method for the direct and simultaneous assessment of LDL- and HDL-cholesterol with ultracentrifugation and established methods
37. Adding albumin normalizes electrophoretic mobility of lipoproteins in sera with high concentrations of free fatty acids
38. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
39. Citation classics in clinical chemistry
40. Measurement of low-density-lipoprotein cholesterol in serum: A status report
41. SI units and the Friedewald formula
42. The Friedewald equation for the determination of low-density-lipoprotein cholesterol: A special case
43. Comparison of an immunoprecipitation method for direct measurement of LDL-cholesterol with β-quantification (ultracentrifugation)
44. Variability of lipid measurements: Relevance for the clinician
45. Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma
46. Alcohol and blood lipids. The Cooperative Lipoprotein Phenotyping study
47. The Friedewald formula: Statistical acrobatics?
48. Estimation of VLDL cholesterol in hyperlipidemia
49. Black-white differences in serum lipids and lipoproteins in Evans County
50. Application of Friedewald's LDL-cholesterol estimation formula to serum lipids in the Japanese population
51. Friedewald's LDL-cholesterol estimation formula in a Japanese American population
52. Estimation of low-density lipoprotein by the Friedewald formula and by electrophoresis compared
53. Calculation of low-density lipoprotein cholesterol with use of triglyceride/cholesterol ratios in lipoproteins compared with other calculation methods
54. Measurement of LDL and VLDL cholesterol with precipitation techniques. A comparison with the ultracentrifugation method
55. Calculation of LDL-cholesterol by using apolipoprotein B for classification of nonchylomicronemic dyslipemia
56. Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apoB as indices of hyperapobetalipoproteinemia and small dense LDL
57. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints
58. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk
59. Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states
60. Postprandial effect of a high fat meal on plasma lipid, lipoprotein cholesterol and apolipoprotein measurements
61. Poor applicability of the Friedewald formula in the assessment of serum LDL cholesterol for clinical purposes
62. Effect of serum lipoprotein(a) on estimation of low-density lipoprotein cholesterol by the Friedewald formula
63. Lipoprotein(a) is included in low-density lipoprotein by NCEP definition
64. Validation of the Friedewald formula for the measurement of low density lipoprotein cholesterol in insulin-dependent diabetes mellitus
65. Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus
66. A more valid measurement of low-density lipoprotein cholesterol in diabetic patients
67. Measurement of plasma LDL cholesterol in patients with diabetes
68. Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patients
69. Is the determination of LDL cholesterol according to Friedewald accurate in CAPD and HD patients?
70. Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis
71. Limitations of the Friedewald formula for estimating low-density lipoprotein cholesterol in alcoholics with liver disease
72. Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: The Postmenopausal Estrogen/Progestins Interventions (PEPI) trial
73. Measurement of triglycerides and lipoproteins
74. A simple specific method for precipitation of low density lipoproteins
75. Five methods for determining low-density lipoprotein cholesterol compared
76. Precipitation of LDL with sulphopolyanions: A comparison of two methods for LDL cholesterol determination
77. An evaluation of three commercial methods for the determination of LDL-cholesterol
78. Precipitation of LDL with sulfated polyanions: Three methods compared
79. Insufficient accuracy and specificity of polyanion precipitation methods for quantifying low-density lipoproteins
80. Comparison of two assays for measuring LDL cholesterol
81. LDL-cholesterol determination in blood serum following precipitation of LDL with polyvinylsulfate
82. Precipitation methods for the determination of LDL-cholesterol
83. Cholesterol, phospholipid and apoB composition of LDL: Comparison of precipitation and ultracentrifugation methods
84. Are 'precipitated LDL' really low density lipoproteins?
85. Evaluation of a commercial reagent for precipitating human serum low-density lipoprotein
86. Evaluation of a commercial kit for the determination of LDL cholesterol in serum based on precipitation of LDL with dextran sulfate
87. A simple precipitation-based method for the screening of type III hyperlipoproteinemia
88. Accurate direct determination of low-density lipoprotein cholesterol using an immunoseparation reagent and enzymatic cholesterol assay
89. Performance of a direct, immunoseparation based LDL-cholesterol method compared to Friedewald calculation and a polyvinyl sulphate precipitation method
90. Comparison of methods for measurement of apolipoprotein B and cholesterol in low-density lipoproteins
91. Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated
92. Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyperlipidemic pediatric population
93. Performance characteristics of the Lipidirect magnetic LDL cholesterol reagent
94. LDL-cholesterol: The application of magnetic on-line separation and analysis of LDL-cholesterol on the Vitros 950 and Paramax 720 chemistry analyzers
95. Evaluation of the Lipidirect magnetic LDL cholesterol in non-fasting adults
96. Evolution of methods for measurement of high-density lipoprotein cholesterol: From ultracentrifugation to homogeneous assays
97. Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and α-cyclodextrin sulfate
98. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated α-cyclodextrin
99. A homogeneous assay for the selective measurement of LDL-cholesterol in serum. Enzymatic selective protection method
100. Analytical and clinical evaluation of two homogeneous assays for LDL-cholesterol in hyperlipidemic patients
101. Low-density lipoprotein cholesterol can be chemically measured: A new superior method
102. Analytical and clinical performance of a detergent-based homogeneous LDL cholesterol assay: A multicenter evaluation
103. Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg(2+) method
104. Evaluation of two different homogeneous assays for LDL-cholesterol in lipoprotein-X-positive serum
105. Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL: Comparison of three homogeneous methods
106. Which cholesterol are we measuring with the Roche direct, homogeneous LDL-C Plus assay?
107. Direct measurement of LDL-C in children: Performance of two surfactant-based methods in a general pediatric population
108. 2+ method
109. Measurement of serum low density lipoprotein-cholesterol in patients with hypertriglycemia
110. Single vertical spin density gradient ultracentrifugation
111. Evaluation of a homogeneous direct LDL-cholesterol assay in diabetic patients: Effect of glycemic control
112. New homogeneous assays for estimation of serum HDL and LDL-cholesterol levels